Trader Alert: Unusual Volume Spotted in Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics

On November 9 analysts at Canaccord Genuity updated its forecast on NKTR with an initial rating of "Buy". Therefore 80% are positive. Nektar Therapeutics has a 12 month low of $11.41 and a 12 month high of $33.67.

The stock is now showing YTD performance of 164.87 Percent. Arizona State Retirement System increased its position in Nektar Therapeutics by 1.0% in the 2nd quarter. The brokerage now has an "overweight" rating on the biopharmaceutical company's stock. William Blair reissued an outperform rating on shares of Nektar Therapeutics in a report on Tuesday, July 18th.

Nektar Therapeutics (NASDAQ:NKTR) traded up $0.76 during midday trading on Monday, hitting $32.50. Cowen and Company began coverage on shares of Nektar Therapeutics in a research report on Tuesday, November 7th. As of the last earnings report the EPS was $-0.71 with 157.47M shares outstanding. Higher relative volume you will have more liquidity in the stock which will tighten spreads and allow you to trade with more size without a ton of slippage. "Has $6,567,000 Stake in Nektar Therapeutics (NKTR)" was posted by and is owned by of. It has outperformed by 24.82% the S&P500.

When investing in a volatile security, the risk of success is increased just as much as the risk of failure. Its up 0.72, from 1.17 in 2017Q1. It increased, as 14 investors sold Vonage Holdings Corp. shares while 65 reduced holdings. Royal Bancorp Of Canada owns 2,356 shares. D E Shaw And Communications reported 0% stake. Rhenman & Ptnrs Asset Mgmt Ab holds 2.23% or 795,000 shares in its portfolio. Finally, Piedmont Investment Advisors LLC boosted its stake in Nektar Therapeutics by 264.6% during the 2nd quarter. Its down 2.62% from 9.15M shares previously. Northwestern Mutual Wealth holds 173 shares or 0% of its portfolio. Citigroup owns 203,289 shares or 0% of their USA portfolio. Bragg Financial Advisors Inc, a North Carolina-based fund reported 54,428 shares. Mark Sheptoff Financial Planning LLC increased its stake in shares of Nektar Therapeutics by 79.4% during the 3rd quarter. Louisiana State Employees Retirement System owns 63,200 shares.

Nektar Therapeutics (NASDAQ NKTR) opened at $32.50 on Friday. Invesco Ltd holds 3.61M shares. Cibc Asset Mngmt Incorporated accumulated 10,366 shares.

TRADEMARK VIOLATION WARNING: "Nektar Therapeutics (NKTR) PT Raised to $44.00 at J P Morgan Chase & Co" was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune.

Since May 16, 2017, it had 0 buys, and 2 sales for $15.82 million activity. 147.16 million shares or 3.57% more from 142.09 million shares in 2017Q1 were reported. $28,348 worth of Nektar Therapeutics (NASDAQ:NKTR) shares were sold by Gergel Ivan P. $61,504 worth of Nektar Therapeutics (NASDAQ:NKTR) was sold by Nicholson John.'s news article titled: "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q3 2017 Results - Earnings ..." with publication date: November 08, 2017 was also an interesting one. Also, Director R Scott Greer acquired 15,000 shares of the firm's stock in a transaction dated Monday, October 24th.

Nektar Therapeutics is a biopharmaceutical firm that discovers and develops medicines in areas of high unmet medical need. The most current P/E ratio is N/A and the market value is 5.84B. The Company is engaged in the development of a pipeline of drug candidates that utilize its PEGylation and advanced polymer conjugate technology platforms, which are created to enable the development of new molecular entities that target known mechanisms of action. It leverages its chemistry platform to discover and design new drug candidates.

Robertson Opportunity Capital Llc holds 3.21% of its portfolio in Cypress Semiconductor Corporation for 370,000 shares. 1492 Capital Management LLC cut its ownership by shedding 104 shares a decrease of 0.3% from 06/30/2017 to 09/30/2017. Following the completion of the transaction, the senior vice president now owns 52,016 shares of the company's stock, valued at $1,508,464. Massachusetts-based Wellington Management Ltd Liability Partnership has invested 0.02% in Vonage Holdings Corp. Deroy & Devereaux Private Investment Counsel Inc, a Michigan-based fund reported 1.33 million shares.

Analysts await Plantronics Inc (NYSE:PLT) to report earnings on January, 30. During the same quarter in the prior year, the firm earned ($0.32) earnings per share.

As of quarter end Amalgamated Bank had sold a total of 86 shares trimming its stake by 0.4%.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.



Other news